Centalun

Centalun

Centalun
Systematic (IUPAC) name
2-methyl-1-phenylbut-3-yne-1,2-diol
Clinical data
Legal status
  • Unscheduled
Identifiers
CAS Registry Number  YesY
ATC code None
PubChem CID:
ChemSpider  N
Chemical data
Formula C11H12O2
Molecular mass 176.212 g/mol
 N   

Centalun was developed by Boehringer Ingelheim in 1962[1] and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABAA receptor.[2] It was previously used for sedation in medical procedures such as surgery,[3] orthopedics[4] and gynecology,[5] although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the CSA and therefore remains unregulated as a drug of abuse.

References

  1. ^ BE Patent 618130
  2. ^
  3. ^
  4. ^
  5. ^